泌尿系疾病患者感染标本中大肠杆菌耐药性的检测

被引:9
作者
杜广辉 [1 ]
朱旭慧 [2 ]
袁晓奕 [1 ]
孙自镛 [2 ]
李广为 [1 ]
陈园 [1 ]
杨为民 [1 ]
叶章群 [1 ]
机构
[1] 华中科技大学同济医学院附属同济医院泌尿外科
[2] 华中科技大学同济医学院附属同济医院感染科
关键词
泌尿系统感染; 致病菌; 大肠杆菌; 耐药性;
D O I
暂无
中图分类号
R691 [一般疾病];
学科分类号
1002 ; 100210 ;
摘要
目的监测泌尿系疾病患者感染标本中大肠杆菌耐药状况,为临床用药提供参考。方法回顾性分析2003年1-12月泌尿外科住院患者感染标本中分离的32株大肠杆菌对常用抗生素耐药性的检测结果,其中,菌株来自尿液20株、分泌物4株、脓液4株、引流液2株、血液和精液各1株。结果临床常用的22种抗生素中,耐药率>50%者10种,占45%。四环素的敏感率为0,氨苄西林、哌拉西林和萘啶酸的敏感率<10%。敏感率>80%者为阿米卡星、亚胺培南、头孢他啶、呋喃妥因、头孢哌酮、头孢吡肟共6种,未发现亚胺培南耐药菌株。结论泌尿系统感染致病菌中大肠杆菌的耐药性严重,其中以应用历史长、范围广的口服类抗生素的耐药性最为严重。
引用
收藏
页码:278 / 280
页数:3
相关论文
共 10 条
[1]  
Changing trends in bacteri-ology of burns in the burns un it,D elh i,Ind ia. S ingh NP,Goyal R,Manchanda V,et al. Burns . 2003
[2]  
Increasing resistance tofluoroqu inolones in Escherich ia coli from urinary tract infections inthe Netherlands. Goettsch W,van PeltW,Nagelkerke N,et al. Journal of Antimicrobial Chemotherapy . 2000
[3]  
Current m icrob iological andclin ical aspects of urinary tract infections. Bonad io M,M ein i M,Sp italeri P,et al. European Urology . 2001
[4]  
Mu lticenter surveillance of antim i-crob ial resistance ofmajor bacterial pathogens in intensive care un itsin 2000 in Taiwan. Hsueh PR,L iu YC,Yang D,et al. M icrob D rug Resist . 2001
[5]  
Non-hosp ital antim icrob ial usageand resistance in commun ity-acqu ired Escherich ia coli urinary tractinfection. Kahlm eter G,M enday P,Cars O. Journal of Antimicrobial Chemotherapy . 2003
[6]  
Increasing prevalence ofantim icrob ial resistance among Enterobacteriaceae uropathogens inDakar,Senegal:a mu lticenter study. D rom igny JA,Ndoye B,Macondo EA,et al. D iagn M icrob iol Infect D is . 2003
[7]  
Antib iotic resistance amongE.coli isolates from urinary tract infections(1999-2000):a mu lti-center study. Smaou iH,Mah joub i F,Boutiba I,et al. Tun isM ed . 2003
[8]  
C ross-resistance and associated resistancein 2478 Escherich ia coli isolates from the Pan-European ECO.SENSProject surveying the antim icrob ial susceptib ility of pathogens fromuncomplicated urinary tract infections. Kahlm eter G,M enday P. Journal of Antimicrobial Chemotherapy . 2003
[9]  
Fluoroqu inolone resistance of hu-man pathogen ic bacteria.ResistantE.coli now appearing in Sweden. Osterlund A,O lsson-L iljequ ist B. Lakartidn ingen . 1999
[10]  
Acute uncomplicated UTIand E.coli resistance:implications for first-line emp irical antib iotictherapy. Perfetto EM,Keating K,M erchant S,et al. JManag Care Pharm . 2004